| Product Code: ETC12626195 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Jordan Oncology Anti-Cancer Drugs Market Overview |
3.1 Jordan Country Macro Economic Indicators |
3.2 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Jordan Oncology Anti-Cancer Drugs Market - Industry Life Cycle |
3.4 Jordan Oncology Anti-Cancer Drugs Market - Porter's Five Forces |
3.5 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.9 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Jordan Oncology Anti-Cancer Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of cancer in Jordan |
4.2.2 Advancements in technology leading to the development of new anti-cancer drugs |
4.2.3 Growing awareness about the importance of early cancer detection and treatment |
4.3 Market Restraints |
4.3.1 High cost of oncology drugs |
4.3.2 Stringent regulations and approval processes for new drugs |
4.3.3 Limited access to advanced cancer treatments in certain regions of Jordan |
5 Jordan Oncology Anti-Cancer Drugs Market Trends |
6 Jordan Oncology Anti-Cancer Drugs Market, By Types |
6.1 Jordan Oncology Anti-Cancer Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.1.4 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.1.5 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Hormone Therapy, 2021 - 2031F |
6.1.6 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.1.7 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Precision Medicine, 2021 - 2031F |
6.2 Jordan Oncology Anti-Cancer Drugs Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Lung Cancer, 2021 - 2031F |
6.2.3 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.2.4 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Prostate Cancer, 2021 - 2031F |
6.2.5 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.2.6 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Leukemia, 2021 - 2031F |
6.3 Jordan Oncology Anti-Cancer Drugs Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.3 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.3.4 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.3.5 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Topical, 2021 - 2031F |
6.3.6 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.4 Jordan Oncology Anti-Cancer Drugs Market, By Therapy Type |
6.4.1 Overview and Analysis |
6.4.2 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.4.3 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.4.4 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Hormone Therapy, 2021 - 2031F |
6.4.5 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.4.6 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.5 Jordan Oncology Anti-Cancer Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.5.3 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5.4 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.5.5 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Specialty Pharmacies, 2021 - 2031F |
6.5.6 Jordan Oncology Anti-Cancer Drugs Market Revenues & Volume, By Mail Order Pharmacies, 2021 - 2031F |
7 Jordan Oncology Anti-Cancer Drugs Market Import-Export Trade Statistics |
7.1 Jordan Oncology Anti-Cancer Drugs Market Export to Major Countries |
7.2 Jordan Oncology Anti-Cancer Drugs Market Imports from Major Countries |
8 Jordan Oncology Anti-Cancer Drugs Market Key Performance Indicators |
8.1 Number of clinical trials for oncology drugs conducted in Jordan |
8.2 Percentage of cancer patients receiving timely and appropriate treatment |
8.3 Investment in research and development of new anti-cancer drugs in Jordan |
9 Jordan Oncology Anti-Cancer Drugs Market - Opportunity Assessment |
9.1 Jordan Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Jordan Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 Jordan Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Jordan Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.5 Jordan Oncology Anti-Cancer Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Jordan Oncology Anti-Cancer Drugs Market - Competitive Landscape |
10.1 Jordan Oncology Anti-Cancer Drugs Market Revenue Share, By Companies, 2024 |
10.2 Jordan Oncology Anti-Cancer Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here